Catalyst Wire Dossier Catalyst Wire Dossier

CD07805/47 Gel 0.5%

CD07805/47 Gel 0.5% · Galderma R&D
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD07805/47 Gel 0.5%, covering 2014-07-10 to 2014-07-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea [Phase 3]

See pricing